Irving, Texas (RBC Life Sciences: OTCBB: RBCL) — A national business advisory firm recently featured RBC Life Sciences, a leading global provider of evidence-based nutritional supplements and personal care products, in an interview highlighting the company's growth.
In the interview, AMR Research referred to RBC Life Sciences as "a small company that has been growing at a rapid clip." In 2007, for example, RBC Life Sciences grew nearly 25 percent on the back of rapid domestic and international growth within the company's nutritional supplements and medical products subsidiaries.
"RBC Life Sciences subsidiaries possess an incredible synergy," said RBC Life Sciences President John Price. "On the one hand, MPM Medical Inc. has a range of wound care and pain management products that are increasingly gaining accolades within the industry. Many of these products are aloe-based as are many of the company's nutritional supplements and personal care products. These companies also share the distinction of their products being backed by evidence-based studies and science."
Price said RBC Life Sciences is well-prepared to capitalize on one of the most momentous changes in the health and wellness industries globally. Economist Paul Zane Pilzer has predicted that health and wellness will become the next trillion-dollar industry. With health care costs increasing beyond the reach of many, people are focusing on maintaining optimal health, Pilzer said.
"Proper diet is critical for optimal health," Price said. "Few people, however, have the discipline to maintain such a diet. Even if they did, many of our foods these days simply don't have the same levels of important vitamins, minerals and phytonutrients that they had just a generation ago."
An article in the 2002 Journal of the American Medical Association said it was "prudent" for American adults to take nutritional supplements because they were unlikely to receive the vitamins and minerals their bodies need from diet alone. But not all nutritional supplements are created equal.
Price said he believes the RBC Life Sciences is uniquely situated because its products are based on validated science and proprietary technologies. RBC Life Sciences' products are formulated, tested and ensured for safety in the company's state-of-the-art laboratory. All ingredients are harvested and manufactured according to national Good Manufacturing Practices.
RBC Life Sciences is a pioneer in the true definition of the word. The company's founder, CEO Clinton Howard, made history during the early 1980s when he organized a team of scientists to unlock the age-old mystery behind the healing properties of the aloe vera plant. For centuries, scribes—everyone from Old Testament authors and Egyptian pharaohs to Aristotle and Alexander the Great—have sung the praises of the unassuming plant, yet none were able to pinpoint why it was so beneficial to health.
Howard's team cracked the code when it isolated the active ingredient—a long-chain polysaccharide found in the inner leaf gel of the plant. Dubbed 'acemannan,' this glyconutrient holds the key to the aloe vera's health benefits.
"This dedication to science is the bedrock upon which RBC Life Sciences is built," Price said. "Today the company not only has some of the most efficacious aloe-based products on the market but also some of the industry's most innovative multivitamin, multimineral and antioxidant nutritional products."
About RBC Life Sciences
RBC Life Sciences develops, manufactures and markets high quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical brand, RBC Life Sciences also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the Company's Web site at www.rbclifesciences.com.
The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange.
Contacts:
Alan Van Zelfden
Van Zelfden Communications
469-964-0216
Ann Billings
RBC Life Sciences, Inc.
972-893-4000
search blogs
share it
blog it
